Caffeine / Ca+2 Cancer Research Results

Caff, Caffeine: Click to Expand ⟱
Features:
Caffeine is a natural chemical with stimulant effects. It is found in coffee, tea, cola, cocoa, guarana, yerba mate, and over 60 other products.

Caffeine (CAF; 1,3,7-trimethylxanthine) — dietary methylxanthine (natural product / drug) found in coffee/tea/cacao and used in OTC stimulants and some analgesic combinations. Sources: coffee/tea, supplements, OTC meds.

Primary mechanisms (conceptual rank):
1) Adenosine receptor antagonism (A1/A2A) → wakefulness, neuromodulation
2) ↑ Catecholamines / CNS arousal → performance + mood effects
3) PDE inhibition (cAMP/cGMP ↑) (high concentration only)
4) Cell-cycle checkpoint interference (ATM/ATR-related) (high concentration only)

Bioavailability / PK relevance: Rapid oral absorption; widely distributed (including CNS); hepatic metabolism (CYP1A2) with large inter-individual variability; tolerance develops with habitual use.

In-vitro vs oral exposure: Many “anti-cancer” mechanisms rely on supra-physiologic concentrations (PDE inhibition, checkpoint override) vs typical dietary plasma levels; clinically relevant mechanism is adenosine antagonism. This is a major translation constraint. Physiologic human exposures after ordinary intake are in the low micromolar range relevant to adenosine receptor occupancy, whereas many anticancer in-vitro effects commonly attributed to caffeine, especially PDE inhibition, Ca²⁺ release, and checkpoint override, usually require far higher concentrations, often approaching high-micromolar to millimolar ranges.

Clinical evidence status: Extensive human data for alertness/performance; oncology evidence is mainly epidemiologic + preclinical (no anticancer indication).

Natural stimulant

-Caffeine appears to interact with several pathways relevant to cancer biology—including adenosine receptor signaling, DNA damage response, cell cycle regulation, apoptosis, PI3K/Akt/mTOR, and NF-κB
—Its overall impact likely depends on the cancer type, stage, microenvironment, and the dosage administered

Caffeine — Cancer vs Normal Cell Pathway Map

RankPathway / AxisCancer CellsNormal CellsTSFPrimary EffectNotes / Interpretation
1Adenosine signaling (A1/A2A antagonism) ↓ adenosine-mediated suppression (context-dependent)↑ arousal/neuromodulationP/R Immune + signaling tone shift A2A antagonism can be immunostimulatory in tumor-microenvironment contexts; not a tumor-directed cytotoxin and highly context-dependent.
2cAMP signaling / catecholamine tone ↔ (context-dependent)↑ (acute stimulation)P/R Systemic stimulation Stress-hormone effects can be bidirectional for cancer biology depending on context; not a central anticancer mechanism.
3DNA damage response checkpoints (ATM/ATR) ↓ checkpoints (high concentration only)↓ checkpoints (high concentration only)P/R S/G2 checkpoint override Classic in vitro effect used to radiosensitize/chemosensitize; translation limited by concentration requirements.
4Cell cycle / proliferation ↓ or ↔ (model-dependent; high concentration only)R/G Cytostatic effects (experimental) Observed in vitro; not consistent at dietary exposures.
5Apoptosis ↑ (high concentration only)R/G Experimental cytotoxicity Typically downstream of checkpoint disruption/ROS stress in vitro.
6PDE inhibition ↑ cAMP/cGMP (high concentration only)↑ cAMP/cGMP (high concentration only)P/R Second-messenger amplification PDE inhibition is not dominant at typical intake; becomes relevant only at higher exposures.
7ROS ↔ / ↑ (high concentration only)P/R Not a primary redox drug Some models show oxidative stress at high dose; not canonical at physiologic exposure.
8NRF2 R/G No primary modulation Not a canonical caffeine-first axis.
9HIF-1α ↔ (limited; model-dependent)G Not primary Any hypoxia-pathway effects are indirect and not robustly classed as core.
10Ferroptosis ↔ (not established)R/G Not canonical No consistent ferroptosis program attributed to caffeine.
11Ca²⁺ signaling P/R No primary role Not a dominant mechanistic axis at typical intake.
12Clinical Translation Constraint ↓ (constraint)↓ (constraint) Exposure + tolerance + sleep effects Most tumor-directed mechanisms require high concentrations; chronic use limited by sleep disruption/anxiety in susceptible individuals and tolerance to stimulant effects.

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr



Caffeine — AD relevance: Strong mechanistic fit via adenosine A2A antagonism (synaptic plasticity + neuroinflammation modulation). Human data support acute attention benefits; dementia/AD risk signals are largely observational (not disease-modifying approval).

Primary mechanisms (conceptual rank):
1) A2A antagonism → ↑ synaptic efficiency / plasticity
2) ↓ Neuroinflammation (microglial tone; cytokine signaling) (context-dependent)
3) ↓ Aβ/tau-associated toxicity pathways (preclinical; model-dependent)
4) Cerebrovascular / glymphatic-sleep tradeoffs (alertness vs sleep architecture effects)

Bioavailability / PK relevance: Rapid CNS penetration; effects are acute (minutes–hours) but chronic patterns depend on tolerance and sleep timing.

Clinical evidence status: Supportive (symptom/attention); AD disease-modifying efficacy not established.

Caffeine — AD / Neurodegeneration Pathway Map

RankPathway / AxisCellsTSFPrimary EffectNotes / Interpretation
1Adenosine A2A antagonism (synaptic plasticity) P/R Improved signaling efficiency Core neuro mechanism; overlaps with the rationale for A2A antagonists in neurodegeneration frameworks.
2Neuroinflammation (microglial activation; cytokines) ↓ (context-dependent)R/G Lower inflammatory stress Often attributed to adenosine-pathway modulation; magnitude is model- and state-dependent.
3ROS / mitochondrial stress ↔ / ↓ (supportive)P/R Resilience support (secondary) Not a primary antioxidant; changes are typically indirect via signaling state and inflammation.
4Aβ / tau-associated pathology ↔ / ↓ (preclinical; model-dependent)G Reduced proteotoxic stress (hypothesis) Evidence is stronger in models than in biomarker-confirmed human AD studies.
5Ca²⁺ excitotoxicity interplay ↔ (indirect)P/R Not primary Could be secondary to synaptic modulation; treat as secondary unless explicit Ca²⁺ endpoints exist.
6Sleep architecture / glymphatic coupling ↑ alertness; ↓ sleep (timing-dependent)R/G Tradeoff axis Potential benefit via daytime function but potential harm if it chronically degrades sleep quality (sleep is relevant to amyloid clearance hypotheses).
7Clinical Translation Constraint ↓ (constraint) Timing + tolerance + heterogeneity Benefits depend strongly on dosing/timing and individual sensitivity; not disease-modifying therapy.

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr



Ca+2, Calcium Ion Ca+2: Click to Expand ⟱
Source:
Type:
In all eukaryotic cells, intracellular Ca2+ levels are maintained at low resting concentrations (approximately 100 nM) by the activity of the major Ca2+ extrusion system, the plasma membrane Ca2+-ATPase (PMCA), which exchanges extracellular protons (H+) for cytosolic Ca2+.
Indeed, sustained elevation of [Ca2+]C in the form of overload, saturating all Ca2+-dependent effectors, prolonged decrease in [Ca2+]ER, causing ER stress response, and high [Ca2+]M, inducing mitochondrial permeability transition (MPT), are considered to be pro-death factors.
In cancer the Ca2+-handling toolkit undergoes profound remodelling (figure 1) to favour activation of Ca2+-dependent transcription factors, such as the nuclear factor of activated T cells (NFAT), c-Myc, c-Jun, c-Fos that promote hypertrophic growth via induction of the expression of the G1 and G1/S phase transition cyclins (D and E) and associated cyclin-dependent kinases (CDK4 and CDK2).
Thus, cancer cells may evade apoptosis through decreasing calcium influx into the cytoplasm. This can be achieved by either downregulation of the expression of plasma membrane Ca2+-permeable ion channels or by reducing the effectiveness of the signalling pathways that activate these channels. Such protective measures would largely diminish the possibility of Ca2+ overload in response to pro-apoptotic stimuli, thereby impairing the effectiveness of mitochondrial and cytoplasmic apoptotic pathways.
Voltage-Gated Calcium Channels (VGCCs): Overexpression of VGCCs has been associated with increased tumor growth and metastasis in various cancers, including breast and prostate cancer.
Store-Operated Calcium Entry (SOCE): SOCE mechanisms, such as STIM1 and ORAI1, are often upregulated in cancer cells, contributing to enhanced cell survival and proliferation.
High intracellular calcium levels are associated with increased cell proliferation and migration, leading to a poorer prognosis. Calcium signaling can also influence hormone receptor status, affecting treatment responses.
Increased Ca²⁺ signaling is associated with advanced disease and metastasis. Patients with higher CaSR expression may have a worse prognosis due to enhanced tumor growth and resistance to apoptosis. -Ca2+ is an important regulator of the electric charge distribution of bio-membranes.


Scientific Papers found: Click to Expand⟱
528- MF,  Caff,    Pulsed electromagnetic fields affect the intracellular calcium concentrations in human astrocytoma cells
- in-vitro, GBM, U373MG
Ca+2↑, TumCP∅, TumCD∅, eff↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death

TumCD∅, 1,  

Migration

Ca+2↑, 1,   TumCP∅, 1,  

Drug Metabolism & Resistance

eff↑, 1,  
Total Targets: 4

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: Ca+2, Calcium Ion Ca+2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:52  Target#:38  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page